Deepak R. Talreja, MD, discusses the current advances in lipidology. Here he discusses lipid management that utilizes PCSK9 inhibitors, how these effect cholesterol, how to determine if your patient is a candidate for this type of treatment, and what complications one might expect from this treatment.
Published
February 16, 2018
Created by
Related Presenters
Cardiology, Internal Medicine
Board Certifications American Board of Internal Medicine - Cardiovascular Disease American Board of Internal Medicine - Internal Medicine American Board of Internal Medicine - Interventional Cardiology Gender Male Medical ...